Eli Lilly Gets FDA Approval for Zepbound

The FDA just approved Eli Lilly's Zepbound for sleep apnea — and Medicare coverage could be next
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration (FDA) as the first prescription drug to help alleviate moderate-to-severe obstructive sleep apnea (OSA) for adults with obesity.
FDA Approves Zepbound for Sleep Apnea in Patients With Obesity
The U.S. Food and Drug Administration has approved Zepbound (tirzepatide) as the first prescription medication for the
Lilly’s Zepbound Snags First Ever Sleep Apnea Drug Approval
The mega-blockbuster weight loss GLP-1 drug is now also approved to treat obstructive sleep apnea in adults with obesity, in combination with diet and exercise.
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe obstructive sleep apnea for people with obesity.
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but potentially serious sleep-related breathing disorder, marking it the first medication for certain patients with the condition.
Lilly Obesity Drug Gets First US Approval for Sleep Apnea
Eli Lilly & Co.’s weight-loss shot Zepbound won approval in the US as the first drug to treat sleep apnea, opening the door for broader insurance coverage of the blockbuster medicine.
Hosted on MSN28d
Medicare Could Pay for Wegovy. Don’t Count On It.
With less than two months left in office, the Biden administration said Tuesday it would seek to let Medicare pay for weight-loss drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound ...
Eli Lilly Stock Is Rising Monday: What's Going On?
Eli Lilly and Company (NYSE: LLY) shares are trading higher Monday. The upward momentum in the stock comes after the FDA ...
STAT1d
Vertex drug for cystic fibrosis wins approval
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Health Affairs8d
Proposed Rule Would Expand Medicare And Medicaid Coverage For Anti-Obesity Medications
Senator Bernie Sanders (I-VT), for example, stated that “unless Medicare demands that Novo Nordisk and Eli Lilly substantially reduce the prices for these anti-obesity drugs, Medicare premiums ...
Medicare negotiated prices higher elsewhere
The prices were compared to 11 other countries{beacon} Health Care Health Care   The Big Story Medicare negotiated prices ...